Dr. David Brett Sable, MD, PhD

Dr. Sable practices at Academic Alliance in Dermatology in Hudson, Florida.

Dr. Sable's NPI, 1245216092, was assigned on December 22, 2005. Dr. Sable graduated from Tufts University School Of Medicine in 1996. Dr. Sable holds Florida license ME91264.

Dr. Sable's primary practice is Academic Alliance in Dermatology, at 13910 Fivay Rd, Hudson, FL 34667 in Pasco County. The practice phone is (813) 882-9986.

Dr. Sable's primary practice is Academic Alliance in Dermatology in Hudson, Florida. The medical group on file is Academic Alliance in Dermatology. Dmand AI also links Dr. Sable to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sable practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Sable's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Sable is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Sable's licenses on file in 7 states: Florida, California, Arizona, New York, Wisconsin, Massachusetts and Michigan.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Sable treats.

CMS data shows 7,089 Medicare services from Dr. Sable across 40 procedure codes in 2024, for 1,175 Medicare patients. Medicare paid $611,946 for them. Every service was in an office.

CMS counts 1,175 Medicare patients who saw Dr. Sable in 2024. The largest group is 65 to 74, with 550 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sable's median patient age at 65, with 48% women.

In 2024, Dr. Sable wrote 4,796 Medicare Part D claims for 1,679 patients. 97% of them were for generic drugs. CMS names the drug for 4,571 of them, across 40 drugs with 11 or more claims each, at $574,709 in total drug cost. In 2023, CMS named 4,097 claims across 38 drugs.

Dr. Sable accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 157 procedures of melanoma (skin cancer) excision by Dr. Sable, more than 96% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Sable. The most frequent topics are Pregnancy Outcome, Preimplantation Diagnosis and Aneuploidy. Dr. Sable has published most often in Fertil Steril. Dr. Sable's most frequent co-authors are Mark Donald Hornstein, MD, Mitchell S. Rein, MD and Michael L. Bentz, MD.

CMS Open Payments shows 197 general payments to Dr. Sable from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Sun Pharmaceutical Industries Inc. paid the most, $2,550.

Dmand AI lists 2 awards for Dr. Sable.

Dr. Sable graduated from Tufts University School Of Medicine in 1996. Dr. Sable is a member of AAD and ASDS.

Dr. Sable is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.